Desohit LD 0.02mg/0.15mg Tablet
By Desohit LD
Rx
21 Tablet in a Strip

Composition
Ethinyl Estradiol(0.02mg) + Desogestrel(0.15mg)

Manufacturer - Maksun Biotech Pvt Ltd
FIRST FLOOR,NANHERA ROAD, KULDEEP NAGAR,AMBALA CANTT 133004 (HARYANA). INDIA

Expires on or after
October, 2025

liver
When taking Desohit LD 0.02mg/0.15mg Tablet, it is important to exercise caution if you have liver disease. Patients with liver issues may require a dose adjustment when using Desohit LD 0.02mg/0.15mg Tablet, so it's crucial to consult your doctor before starting this medication. Avoid using Desohit LD 0.02mg/0.15mg Tablet if you have severe liver disease or active liver disease, as it is not recommended in such cases. It is always best to seek professional medical advice regarding the use of Desohit LD 0.02mg/0.15mg Tablet in relation to your liver health.

kidney
Limited information is available about using Desohit LD 0.02mg/0.15mg Tablet in patients with kidney disease. Please consult your doctor regarding kidney issues before using Desohit LD 0.02mg/0.15mg Tablet.

alcohol
When taking Desohit LD 0.02mg/0.15mg Tablet, caution is recommended when drinking alcohol. Consult your doctor for guidance.

driving
Desohit LD 0.02mg/0.15mg Tablet typically does not impact driving abilities. It is generally safe to drive while using this medication.

pregnancy
During pregnancy, it's crucial to avoid using Desohit LD 0.02mg/0.15mg Tablet due to potential harm to the developing baby. Consult your doctor for appropriate guidance and alternative options.

breastfeeding
Desohit LD 0.02mg/0.15mg Tablet is not safe to use while breastfeeding as it can be harmful to the baby. It is recommended to opt for nonhormonal or progestin-only contraceptives, especially within the first 4 weeks after childbirth.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GYNAECOLOGICAL |
Action Class | - |
₹180
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024